AstraZeneca

NASDAQ: AZN · Real-Time Price · USD
78.49
0.55 (0.71%)
At close: Aug 14, 2025, 3:59 PM
78.52
0.04%
Pre-market: Aug 15, 2025, 07:30 AM EDT

AstraZeneca Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
54.07B 45.81B 44.35B 37.42B
Cost of Revenue
10.21B 8.04B 12.39B 12.44B
Gross Profit
43.87B 37.77B 31.96B 24.98B
Operating Income
10B 8.19B 3.76B 1.06B
Interest Income
345M 301M 95M 43M
Pretax Income
8.69B 6.9B 2.5B -265M
Net Income
7.04B 5.96B 3.29B 112M
Selling & General & Admin
20.22B 18.22B 18.95B 15.68B
Research & Development
13.58B 10.94B 9.76B 9.74B
Other Expenses
56M 618M -514M -1.49B
Operating Expenses
33.86B 29.58B 28.2B 23.92B
Interest Expense
1.68B 1.59B 1.35B 1.28B
Selling & Marketing Expenses
555M 539M 18.95B 15.68B
Cost & Expenses
44.07B 37.62B 40.59B 36.36B
Income Tax Expense
1.65B 938M -792M -380M
Shares Outstanding (Basic)
3.1B 3.12B 3.1B 2.84B
Shares Outstanding (Diluted)
3.13B 3.12B 3.12B 2.85B
EPS (Basic)
2.27 1.91 1.06 0.04
EPS (Diluted)
2.25 1.91 1.06 0.04
EBITDA
15.44B 13.91B 9.09B 5.11B
EBIT
10.43B 8.53B 3.83B 1.01B
Depreciation & Amortization
5.07B 4.93B 5.25B 4.1B